Related Experiment Video
Updated: Oct 13, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
COVID-19 Survival and its impact on chronic kidney disease
Joshua D Long1, Ian Strohbehn1, Rani Sawtell1
1Massachusetts General Hospital, Department of Medicine, Division of Nephrology, Boston, Massachusetts.
Insights
Coronavirus disease 2019 (COVID-19) can cause kidney injury, potentially leading to long-term kidney function decline. Genetic factors and healthcare disparities may worsen this impact, particularly in minority groups.
Area of Science:
- Nephrology
- Infectious Diseases
- Pathophysiology
Background:
- The long-term effects of coronavirus disease 2019 (COVID-19) on kidney function remain largely unknown.
- A significant percentage of hospitalized COVID-19 patients experience chronic health issues post-infection.
Purpose of the Study:
- To review the current understanding of COVID-19-associated kidney injury pathophysiology.
- To summarize the impact of COVID-19 on long-term kidney function and recovery rates from acute kidney injury (AKI).
- To discuss the role of genetic factors and healthcare disparities in post-COVID-19 kidney function decline.
Main Methods:
- Comprehensive review of published literature on COVID-19 and kidney injury.
- Analysis of histopathologic findings from kidney biopsy and autopsy series.
- Summary of recovery rates from COVID-19-associated AKI.
Main Results:
- COVID-19 can cause acute kidney injury through tubular, endothelial, and glomerular damage.
- APOL1 risk alleles and healthcare disparities may disproportionately affect kidney function decline in minority groups post-COVID-19.
- Data on long-term kidney function decline and chronic kidney disease burden after COVID-19 is still emerging.
Conclusions:
- COVID-19 poses a significant threat to kidney health, with potential for long-term sequelae.
- Further prospective studies are crucial to accurately determine the incidence of chronic kidney disease after COVID-19.
- Addressing genetic predispositions and healthcare disparities is essential for mitigating post-COVID-19 kidney complications.
Abstract:
Up to 87% of patients hospitalized with coronavirus disease 2019 (COVID-19) experience chronic sequelae following infection. The long-term impact of COVID-19 infection on kidney function is largely unknown at this point in the COVID-19 pandemic. In this review, we highlight the current understanding of the pathophysiology of COVID-19-associated kidney injury and the impact COVID-19 may have on long-term kidney function. COVID-19-induced acute kidney injury may lead to tubular injury, endothelial injury, and glomerular injury. We highlight histopathologic correlates from large kidney biopsy and autopsy series. By conducting a comprehensive review of published literature to date, we summarize the rates of recovery from COVID-19-associated-AKI. Finally, we discuss how certain genetic differences, including APOL1 risk alleles (a risk factor for collapsing glomerulopathy), coupled with systemic healthcare disparities, may lead to a disproportionate burden of post-COVID-19-kidney function decline among racial and ethnic minority groups. We highlight the need for prospective studies to determine the true incidence of chronic kidney disease burden after COVID-19.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention

